In non metastatic renal cell carcinoma ( I am assuming it is non metastatic)after adequate surgery no additional treatment is required. But as per latest evidence targeted therapy can be given( sunitinib). Compared to the patient not given sunitinb patient who had offered sunitinib their survival is better. But cost is high. Discuss with your oncologist regarding above option
Answered2018-11-07 10:01:51
Let others know if this answer was helpful